S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$166.42
+1.1%
$175.44
$130.96
$182.89
$294.67B0.585.64 million shs5.53 million shs
Credit Suisse Group AG stock logo
CS
Credit Suisse Group
$0.89
$0.89
$0.82
$6.36
$2.77B1.2737.84 million shsN/A
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$126.83
+1.0%
$124.26
$116.32
$147.87
$42.73B0.42.15 million shs4.77 million shs
SVB Financial Group stock logo
SIVB
SVB Financial Group
$0.05
$0.00
$39.40
$597.16
$2.96M1.571.90 million shs14,648 shs
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
$89.32
$91.46
$73.87
$104.21
$13.74B1.341.28 million shs1.12 million shs
UBS Group AG stock logo
UBS
UBS Group
$28.07
-0.2%
$29.63
$18.71
$32.13
N/A1.142.90 million shs1.95 million shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
+0.26%-1.71%-8.35%-0.07%+2.14%
Credit Suisse Group AG stock logo
CS
Credit Suisse Group
0.00%0.00%0.00%0.00%-2.84%
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
-0.27%-0.39%+0.46%+2.35%-9.23%
SVB Financial Group stock logo
SIVB
SVB Financial Group
+2.00%-15.00%-36.25%+5,099,900.00%+5,099,900.00%
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
-0.01%-4.28%-1.48%-5.88%+11.23%
UBS Group AG stock logo
UBS
UBS Group
+0.05%-3.40%-9.73%-3.10%+35.06%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AbbVie Inc. stock logo
ABBV
AbbVie
4.9147 of 5 stars
2.45.04.23.92.92.52.5
Credit Suisse Group AG stock logo
CS
Credit Suisse Group
2.7303 of 5 stars
3.50.02.50.01.40.01.9
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
4.6083 of 5 stars
2.05.04.22.53.33.31.3
SVB Financial Group stock logo
SIVB
SVB Financial Group
N/AN/AN/AN/AN/AN/AN/AN/A
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
3.4124 of 5 stars
1.12.04.21.93.21.71.9
UBS Group AG stock logo
UBS
UBS Group
1.9626 of 5 stars
0.03.01.70.01.70.03.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.77
Moderate Buy$177.436.61% Upside
Credit Suisse Group AG stock logo
CS
Credit Suisse Group
3.00
Buy$8.00798.88% Upside
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
2.00
Hold$131.853.96% Upside
SVB Financial Group stock logo
SIVB
SVB Financial Group
N/AN/AN/AN/A
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
2.20
Hold$98.119.84% Upside
UBS Group AG stock logo
UBS
UBS Group
2.80
Moderate BuyN/AN/A

Current Analyst Ratings

Latest KMB, ABBV, SWK, SIVB, UBS, and CS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$82.00 ➝ $80.00
4/12/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$124.00 ➝ $132.00
4/2/2024
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$105.00 ➝ $107.00
3/28/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$127.00 ➝ $132.00
3/28/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$145.00 ➝ $152.00
3/28/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$123.00
3/28/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$125.00 ➝ $131.00
3/28/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$134.00 ➝ $146.00
3/28/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeIn-Line ➝ Outperform$133.00 ➝ $150.00
3/27/2024
AbbVie Inc. stock logo
ABBV
AbbVie
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$185.00 ➝ $195.00
3/22/2024
AbbVie Inc. stock logo
ABBV
AbbVie
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$188.00 ➝ $190.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$54.32B5.42$16.02 per share10.39$5.78 per share28.79
Credit Suisse Group AG stock logo
CS
Credit Suisse Group
$22.88B0.12$0.25 per share3.51$15.26 per share0.06
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$20.43B2.09$8.88 per share14.28$3.16 per share40.14
SVB Financial Group stock logo
SIVB
SVB Financial Group
$6.21B0.00N/AN/AN/A
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
$15.78B0.87$5.50 per share16.23$59.07 per share1.51
UBS Group AG stock logo
UBS
UBS Group
$65.28BN/A$2.78 per share10.09$16.44 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.86B$2.7360.9613.712.118.95%162.28%14.62%4/26/2024 (Confirmed)
Credit Suisse Group AG stock logo
CS
Credit Suisse Group
-$7.64B$0.651.37N/A15.12%23.83%1.81%N/A
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$1.76B$5.2024.3917.493.758.63%260.47%12.72%4/23/2024 (Confirmed)
SVB Financial Group stock logo
SIVB
SVB Financial Group
N/A$25.350.00N/AN/AN/AN/AN/A
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
-$281.70M-$2.08N/A15.922.41-1.97%2.34%0.89%5/2/2024 (Confirmed)
UBS Group AG stock logo
UBS
UBS Group
$27.85B$8.983.1311.893.2343.70%7.56%0.39%5/7/2024 (Confirmed)

Latest KMB, ABBV, SWK, SIVB, UBS, and CS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
UBS Group AG stock logo
UBS
UBS Group
N/AN/AN/AN/AN/AN/A
5/2/2024N/A
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
$0.53N/A-$0.53N/AN/AN/A  
4/26/2024N/A
AbbVie Inc. stock logo
ABBV
AbbVie
$2.20N/A-$2.20N/AN/AN/A  
4/23/2024N/A
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$1.59N/A-$1.59N/AN/AN/A  
2/6/202412/31/2023
UBS Group AG stock logo
UBS
UBS Group
$0.09-$0.09-$0.18-$0.09$12.06 billion$10.86 billion    
2/2/202412/31/2023
AbbVie Inc. stock logo
ABBV
AbbVie
$2.76$2.79+$0.03$5.12$14.02 billion$14.30 billion    
2/1/2024Q4 2023
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
$0.73$0.92+$0.19$3.87$3.84 billion$3.74 billion    
1/24/202412/31/2023
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$1.53$1.51-$0.02$1.52$4.99 billion$5.00 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.203.73%+7.84%227.11%52 Years
Credit Suisse Group AG stock logo
CS
Credit Suisse Group
$0.055.62%N/A7.69%N/A
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$4.883.85%+3.32%93.85%53 Years
SVB Financial Group stock logo
SIVB
SVB Financial Group
N/AN/AN/AN/AN/A
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
$3.243.63%+5.02%N/A 57 Years
UBS Group AG stock logo
UBS
UBS Group
$0.180.64%+0.15%2.00%N/A

Latest KMB, ABBV, SWK, SIVB, UBS, and CS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/15/2024
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.553.54%4/12/20244/15/20245/15/2024
2/6/2024
UBS Group AG stock logo
UBS
UBS Group
Annual$0.22800.82%5/1/20245/2/20245/3/2024
1/24/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
quarterly$1.223.91%3/7/20243/8/20244/2/2024
2/27/2024
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
quarterly$0.813.66%3/7/20243/8/20243/19/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
5.02
0.87
0.76
Credit Suisse Group AG stock logo
CS
Credit Suisse Group
2.79
1.53
1.53
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
6.94
0.82
0.54
SVB Financial Group stock logo
SIVB
SVB Financial Group
N/AN/AN/A
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
0.67
1.19
0.39
UBS Group AG stock logo
UBS
UBS Group
4.23
1.10
1.09

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
Credit Suisse Group AG stock logo
CS
Credit Suisse Group
11.20%
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
76.29%
SVB Financial Group stock logo
SIVB
SVB Financial Group
92.35%
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
87.77%
UBS Group AG stock logo
UBS
UBS Group
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
50,0001.77 billion1.77 billionOptionable
Credit Suisse Group AG stock logo
CS
Credit Suisse Group
50,4803.11 billionN/AOptionable
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
41,000336.91 million334.83 millionOptionable
SVB Financial Group stock logo
SIVB
SVB Financial Group
N/A59.20 millionN/AN/A
Stanley Black & Decker, Inc. stock logo
SWK
Stanley Black & Decker
50,500153.80 million153.04 millionOptionable
UBS Group AG stock logo
UBS
UBS Group
112,842N/AN/AOptionable

KMB, ABBV, SWK, SIVB, UBS, and CS Headlines

SourceHeadline
UBS hires financial advisor team led by Christopher Toregas in Los AngelesUBS hires financial advisor team led by Christopher Toregas in Los Angeles
businesswire.com - April 19 at 2:55 PM
James Herring and John Gaffney join UBS Private Wealth Management in New York CityJames Herring and John Gaffney join UBS Private Wealth Management in New York City
businesswire.com - April 19 at 9:30 AM
UBS Announces More Layoffs as Credit Suisse Integration ContinuesUBS Announces More Layoffs as Credit Suisse Integration Continues
msn.com - April 19 at 8:39 AM
Exclusive: UBS shuts some China private funds, will lay off staff, sources sayExclusive: UBS shuts some China private funds, will lay off staff, sources say
reuters.com - April 18 at 7:42 AM
UBS plans next round of job cuts after Credit Suisse takeover, banking, wealth management & market units to be affectedUBS plans next round of job cuts after Credit Suisse takeover, banking, wealth management & market units to be affected
livemint.com - April 17 at 11:54 PM
UBS said to plan another round of job cuts in wake of Credit Suisse integrationUBS said to plan another round of job cuts in wake of Credit Suisse integration
msn.com - April 17 at 6:54 PM
UBS plans next round of layoffs in Credit Suisse integration, Bloomberg News reportsUBS plans next round of layoffs in Credit Suisse integration, Bloomberg News reports
reuters.com - April 17 at 6:16 PM
Top-Ranked UBS Team Responds To Clients’ Request To Teach ChildrenTop-Ranked UBS Team Responds To Clients’ Request To Teach Children
forbes.com - April 17 at 8:53 AM
UBS, Nomura Battle to Sell Rate Products to Europe’s Ultra RichUBS, Nomura Battle to Sell Rate Products to Europe’s Ultra Rich
bloomberg.com - April 17 at 8:53 AM
APi Group Announces Pricing of Public Offering of Common StockAPi Group Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - April 17 at 1:14 AM
Hay un “riesgo real” de que la Fed suba las tasas al 6,5%, según UBSHay un “riesgo real” de que la Fed suba las tasas al 6,5%, según UBS
msn.com - April 15 at 7:17 PM
Fed could hike rates rather than cut them: UBS strategistsFed could hike rates rather than cut them: UBS strategists
investmentnews.com - April 15 at 7:17 PM
Fed Hiking Rates to 6.5% Is ‘Real Risk’ for UBS StrategistsFed Hiking Rates to 6.5% Is ‘Real Risk’ for UBS Strategists
bloomberg.com - April 15 at 2:17 PM
Goldman FAs Jump Ship for UBS in New YorkGoldman FAs Jump Ship for UBS in New York
financialadvisoriq.com - April 15 at 9:16 AM
13 UBS advisors in the Philadelphia D.C. Wealth Management Market named to the Barron’s Top 1200 Financial Advisors list13 UBS advisors in the Philadelphia D.C. Wealth Management Market named to the Barron’s Top 1200 Financial Advisors list
finance.yahoo.com - April 15 at 9:16 AM
Wealth management’s rising star in Asia brings in $14 billion client funds to UBSWealth management’s rising star in Asia brings in $14 billion client funds to UBS
businessmirror.com.ph - April 13 at 5:31 PM
New capital requirements for Swiss banks will slow growth at UBS, says finance ministerNew capital requirements for Swiss banks will slow growth at UBS, says finance minister
investing.com - April 13 at 7:02 AM
New capital requirements for Swiss banks will slow growth at UBS, says finance ministerNew capital requirements for Swiss banks will slow growth at UBS, says finance minister
reuters.com - April 13 at 6:16 AM
UBS boosts its New York presenceUBS boosts its New York presence
investmentnews.com - April 12 at 4:17 PM
UBS hires two MDs for TMT in US, more to comeUBS hires two MDs for TMT in US, more to come
globalcapital.com - April 12 at 11:17 AM
UBS Private Wealth Management hires Regina Bronson and Alex Gitomer in New York CityUBS Private Wealth Management hires Regina Bronson and Alex Gitomer in New York City
businesswire.com - April 12 at 10:00 AM
UBS could need $10 bln-$15 bln in extra capital to meet new Swiss rules, analyst saysUBS could need $10 bln-$15 bln in extra capital to meet new Swiss rules, analyst says
reuters.com - April 11 at 12:51 PM
UBS Private Wealth Advisor Jason Stephens named to Barrons Top 1200 Financial Advisors listUBS Private Wealth Advisor Jason Stephens named to Barron's Top 1200 Financial Advisors list
finance.yahoo.com - April 11 at 12:38 PM
Swiss National Bank responds to govt proposals to regulate UBS, other banksSwiss National Bank responds to gov't proposals to regulate UBS, other banks
finance.yahoo.com - April 11 at 7:37 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

AbbVie logo

AbbVie

NYSE:ABBV
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Credit Suisse Group logo

Credit Suisse Group

NYSE:CS
Credit Suisse Group AG is a holding company, which engages in the provision of financial services. It operates through the following four divisions: Wealth Management, Investment Bank, Swiss Bank and Asset Management and four geographic regions: Switzerland, Europe, the Middle East and Africa (EMEA), Asia Pacific, and Americas. The Wealth Management division offers comprehensive wealth management and investment solutions, tailored financing, and advisory services to ultra-high-net-worth (UHNW) and high net-worth (HNW) individuals and external asset managers. The Investment Bank division offers a broad range of financial products and services focused on client-driven businesses and also supports Credit Suisse's Wealth Management division and its clients. The Swiss Bank division offers comprehensive advice and a wide range of financial solutions to private, corporate, and institutional clients in Switzerland. The Asset Management division offers investment solutions and services globally to a broad range of clients, including pension funds, governments, foundations and endowments, corporations, and individuals. The company was founded by Alfred Escher on July 5, 1856 and is headqua
Kimberly-Clark logo

Kimberly-Clark

NYSE:KMB
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names. Its Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The company's K-C Professional segment offers wipers, tissues, towels, apparel, personal protective equipment, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. It also sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to distributors, manufacturing, lodging, office building, food service, and public facilities, as well as through e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.
SVB Financial Group logo

SVB Financial Group

NASDAQ:SIVB
Stanley Black & Decker logo

Stanley Black & Decker

NYSE:SWK
Stanley Black & Decker, Inc. provides hand tools, power tools, outdoor products, and related accessories in the United States, Canada, Other Americas, Europe, and Asia. Its Tools & Outdoor segment offers professional grade corded and cordless electric power tools and equipment, including drills, impact wrenches and drivers, grinders, saws, routers, and sanders; pneumatic tools and fasteners, such as nail guns, nails, staplers and staples, and concrete and masonry anchors; corded and cordless electric power tools; hand-held vacuums, paint tools, and cleaning appliances; leveling and layout tools, planes, hammers, demolition tools, clamps, vises, knives, saws, chisels, and industrial and automotive tools; drill, screwdriver, router bits, abrasives, saw blades, and threading products; tool boxes, sawhorses, medical cabinets, and engineered storage solutions; and electric and gas-powered lawn and garden products. This segment sells its products under the DEWALT, CRAFTSMAN, CUB ADET, BLACK+DECKER, and HUSTLER brands through retailers, third-party distributors, independent dealers, and a direct sales force. The company's Industrial segment provides threaded fasteners, blind rivets and tools, blind inserts and tools, drawn arc weld studs and systems, engineered plastic and mechanical fasteners, self-piercing riveting systems, precision nut running systems, micro fasteners, high-strength structural fasteners, axel swage, latches, heat shields, pins, couplings, fitting, and other engineered products; and attachments used on excavators and handheld tools. This segment sells its products through direct sales force and third-party distributors to the automotive, manufacturing, electronics, construction, aerospace, and other industries. The company was formerly known as The Stanley Works and changed its name to Stanley Black & Decker, Inc. in March 2010. Stanley Black & Decker, Inc. was founded in 1843 and is headquartered in New Britain, Connecticut.
UBS Group logo

UBS Group

NYSE:UBS
UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through five divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-core and Legacy. The company offers investment advice, estate and wealth planning, investing, corporate and banking, and investment management, as well as mortgage, securities-based, and structured lending solutions. It also provides personal banking products and services, such as deposits, credit and debit cards, and online and mobile banking, as well as lending, investments, retirement, and wealth management services; and corporate and institutional solutions, including equity and debt capital markets, syndicated and structured credit, private placements, leasing, traditional financing, and transaction banking solutions for payment and cash management services, trade and export finance, and global custody solutions. In addition, the company offers equities, fixed income, hedge funds, real estate and private markets, indexed and alternative beta strategies, asset allocation and currency investment strategies, customized multi-asset solutions, advisory and fiduciary services, and multi-manager hedge fund solutions and advisory services. Further, it advises clients on strategic business opportunities and helps them raise capital to fund their activities; enables its clients to buy, sell, and finance securities on capital markets and to manage their risks and liquidity; distributes, trades in, finances, and clears cash equities and equity-linked products; structures, originates, and distributes new equity and equity-linked issues; and originates, distributes, manages risk, and provides liquidity in foreign exchange, rates, credit and precious metals. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is headquartered in Zurich, Switzerland.